IPO
General
Grapevine: OTPP, Omega Healthcare, Canara Robeco, Credila in news
A Canadian pension fund is in talks to buy a majority stake in a US-based healthcare BPO, while Canara Bank-backed ......
Markets
Blackstone-backed IGI India climbs on trading debut after $498 mn IPO
International Gemmological Institute (India) Ltd, a diamond certification company controlled by private equity firm Blackstone, made a strong stock market ......
Markets
India brightens IPO prospects for 2025 in Asia Pacific
Dealmakers expect the momentum for new share sales in India, now the world's busiest market for initial public offerings, and Australia ......
Markets
SEBI tightens rules for merchant bankers, IPOs of small firms
India's market regulator late on Wednesday issued tighter regulations for merchant bankers and initial public offerings (IPOs) by small businesses, ......
Manufacturing
What's the upside for Evolvence, Steadview as Unimech floats IPO?
Alternative investment firms Evolvence India and Steadview Capital as well as a private equity fund managed by ValueQuest are sitting ......
Consumer
Vishal Mega Mart jumps 41% in trading debut to $5.8 bn valuation
Shares of India's Vishal Mega Mart surged 41% in debut trade on Wednesday, giving the budget retailer a valuation of $5.8 ......
TMT
MobiKwik surges 85% in trading debut, valued at $474 mn
India's MobiKwik shares soared 85% in their trading debut on Wednesday, valuing the financial technology firm at about 40 billion ......
General
Grapevine: Avendus Capital, Imperial Blue, KKR, OTPP, Akzo Nobel, InCred, and Enel Group in news
The sale process of Pernod Ricard’s Imperial Blue whiskey, Akzo Nobel India Ltd, Enel Group’s renewable energy assets in India ......
Finance
How are Aye Finance's PE-VC backers faring as it eyes over $500 mn valuation in IPO?
A clutch of private equity, venture capital and impact investors are looking to monetise their investment in Aye Finance Ltd through the non-banking ......
Healthcare
Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers
Aragen Life Sciences Ltd, a contract drug development and manufacturing company backed by private equity funds managed by Goldman Sachs, ......